Total Payments
$2,043
2024 Payments
$96.45
Companies
19
Transactions
172
Medicare Patients
1,540
Medicare Billing
$120,305
Payment Breakdown by Category
Food & Beverage$2,032 (99.4%)
Education$11.52 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,032 | 171 | 99.4% |
| Education | $11.52 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $485.80 | 31 | $0 (2024) |
| PFIZER INC. | $399.47 | 61 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $231.35 | 19 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $210.69 | 13 | $0 (2019) |
| Lilly USA, LLC | $117.20 | 8 | $0 (2020) |
| Amarin Pharma Inc. | $106.77 | 7 | $0 (2020) |
| ABBVIE INC. | $99.38 | 6 | $0 (2024) |
| Amgen Inc. | $91.18 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $55.96 | 4 | $0 (2020) |
| Allergan Inc. | $49.60 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96.45 | 5 | ABBVIE INC. ($61.31) |
| 2023 | $31.68 | 2 | Novo Nordisk Inc ($31.68) |
| 2022 | $66.20 | 4 | Novo Nordisk Inc ($66.20) |
| 2021 | $92.80 | 6 | Novo Nordisk Inc ($67.62) |
| 2020 | $118.86 | 8 | Lilly USA, LLC ($33.21) |
| 2019 | $527.06 | 52 | PFIZER INC. ($152.05) |
| 2018 | $442.79 | 40 | PFIZER INC. ($116.71) |
| 2017 | $667.43 | 55 | Merck Sharp & Dohme Corporation ($132.78) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Diabetes | ||||||
| 03/29/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/07/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes | ||||||
| 03/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 10/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Diabetes | ||||||
| 03/21/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes | ||||||
| 12/01/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Diabetes | ||||||
| 11/15/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
| 09/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes | ||||||
| 08/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 07/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: DIABETES | ||||||
| 02/27/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Diabetes | ||||||
| 02/19/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 02/12/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardiovascular | ||||||
| 01/30/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes | ||||||
| 01/22/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: UROLOGY | ||||||
| 01/15/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular | ||||||
| 01/08/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 362 | 848 | $166,729 | $37,676 |
| 2022 | 5 | 432 | 977 | $168,339 | $41,145 |
| 2021 | 4 | 446 | 551 | $94,967 | $24,720 |
| 2020 | 3 | 300 | 470 | $79,557 | $16,764 |
Total Patients
1,540
Total Services
2,846
Medicare Billing
$120,305
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 229 | $64,342 | $14,946 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 292 | $53,465 | $12,121 | 22.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 221 | $36,502 | $7,891 | 21.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 106 | $12,421 | $2,718 | 21.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 83 | 402 | $59,874 | $14,376 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 318 | $54,499 | $13,554 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 170 | $44,755 | $10,547 | 23.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 44 | 50 | $5,193 | $1,651 | 31.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 14 | 37 | $4,017 | $1,017 | 25.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 149 | 204 | $33,300 | $8,581 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 123 | 147 | $23,790 | $6,126 | 25.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 63 | $15,950 | $4,243 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 54 | 59 | $14,634 | $3,752 | 25.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 32 | 38 | $3,273 | $1,150 | 35.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 31 | 40 | $4,020 | $867.96 | 21.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 175 | 305 | $48,876 | $9,892 | 20.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 122 | $25,314 | $5,969 | 23.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 34 | 43 | $5,366 | $903.33 | 16.8% |
About Dr. Crystal Bastin, M.D
Dr. Crystal Bastin, M.D is a Family Medicine healthcare provider based in South Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962453191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Crystal Bastin, M.D has received a total of $2,043 in payments from pharmaceutical and medical device companies, with $96.45 received in 2024. These payments were reported across 172 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,032).
As a Medicare-enrolled provider, Bastin has provided services to 1,540 Medicare beneficiaries, totaling 2,846 services with total Medicare billing of $120,305. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location South Charleston, WV
- Active Since 05/12/2006
- Last Updated 01/13/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1962453191
Products in Payments
- Ozempic (Drug) $239.47
- ELIQUIS (Drug) $216.03
- FARXIGA (Drug) $175.56
- JANUVIA (Drug) $141.07
- Vascepa (Drug) $106.77
- Rybelsus (Drug) $102.88
- Victoza (Drug) $95.30
- TRULICITY (Drug) $77.55
- EVENITY (Biological) $74.03
- ASMANEX (Drug) $73.90
- EUCRISA (Drug) $56.45
- DALVANCE (Drug) $43.99
- CHANTIX (Drug) $42.07
- Edarbyclor (Drug) $39.30
- LINZESS (Drug) $38.30
- VIAGRA (Drug) $34.74
- TOVIAZ (Drug) $34.08
- MYRBETRIQ (Drug) $31.82
- XIFAXAN (Drug) $31.13
- Tresiba (Drug) $29.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Charleston
Dr. Julie Detemple, Md, MD
Family Medicine — Payments: $92,852
Family Medicine $92,852
Dr. Rohit Patel, M.d, M.D
Family Medicine — Payments: $26,815
Family Medicine $26,815
Joshua Bradford, Do, DO
Family Medicine — Payments: $18,789
Family Medicine $18,789
Michelle Burdette, Md, Retired, MD, RETIRED
Family Medicine — Payments: $12,269
Family Medicine $12,269
Dr. Chad Turner, Md, MD
Family Medicine — Payments: $10,522
Family Medicine $10,522
Dr. John Frame, D.o, D.O
Family Medicine — Payments: $8,656
Family Medicine $8,656